Header Logo

Connection

DANIEL D KARP to Lymphopenia

Back to Details
This is a "connection" page, showing publications DANIEL D KARP has written about Lymphopenia.
DANIEL D KARP
Connection Strength
0.190
Lymphopenia
  1. A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors. Oncologist. 2023 Dec 11; 28(12):1100-e1292.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.